The 78-year-old revealed in a 2023 memoir he was “possibly dying” with stage-three non-Hodgkin lymphoma. Read more at straitstimes.com. Read more at straitstimes.com.

Chimeric antigen receptor-T (CAR-T) cell therapy represents a major breakthrough in cancer immunotherapy, providing remarkable clinical benefits for ...

Young cancer cases are rising but a significant number are diagnosed late. A man was given laxatives twice before doctors ...

Little Elliot was diagnosed with juvenile myelomonocytic leukaemia (JMML) on July 11, 2024, at the age of two.

Researchers have found that cells use a "low-pass filter" to ignore short-term physical stress while reacting to sustained ...

Biocompatible molecular spin sensors enable absolute thermometry in the cytoplasm and nucleus of living cancer cells.

According to a new study published by Cancer Reports, combining cisplatin with delta-9 tetrahydrocannabinol (THC) and ...

The body’s “killer” T cells don’t just attack—they strike with astonishing precision, forming a tiny, highly organized ...

When we treat cancer patients, their disease can overcome treatment through its innate capacity to adapt. This is at the ...

Single-cell RNA sequencing is giving researchers a clearer view of why some CAR-T cells persist, expand, kill tumors ...

Two University of Kentucky Markey Cancer Center researchers have each received a Research Scholar Grant from the American ...

This review explains how glucose scarcity, lipid disruption, amino acid deprivation, and toxic metabolites weaken CAR-T cells ...